Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04904692

Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

Sponsor: University Hospital, Ghent

View on ClinicalTrials.gov

Summary

This study is a prospective, observational multicentric study. The study population entails adult patients hospitalized with a high clinical suspicion of COVID-19 and consists of two study arms (SARS-CoV2- vs. SARS-CoV2+).This combined fundamental research project has a dual goal: on the one hand assessing immunological predisposing factors for severe infection and investigating the immunological impact of SARS-CoV2 infection, on the other hand studying viral characteristics. Furthermore, a substudy will examine the pharmacokinetics and pharmacodynamics of hydroxychloroquine in patients receiving this antiviral treatment (REVIVE susbstudy). To answer these research questions, samples will be collected from patients with a high clinical suspicion of COVID-19, hospitalized at UZ Gent and 2 participating hospitals in Ghent (AZ Maria Middelares en AZ Jan Palfijn).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

109

Start Date

2020-03-23

Completion Date

2024-09-30

Last Updated

2024-09-19

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Blood draw

8x9mL EDTA tubes. In subjects treated with hydroxychloroquine treatment an extra EDTA tube (4mL) will be collected for the REVIVE substudy.

PROCEDURE

Bronchoalveolar lavage

Only in case of diagnostic or therapeutic indication.

PROCEDURE

SARS CoV-2 swabs

Nasopharyngeal, oropharyngeal and nasal swabs

Locations (3)

AZ Jan Palfijn

Ghent, Oost-Vlaanderen, Belgium

AZ Maria Middelares

Ghent, Oost-Vlaanderen, Belgium

UZ Gent

Ghent, Oost-Vlaanderen, Belgium